How compliance teams review embedded AI research.
What should a platform's compliance team review before offering third-party AI research to clients?
Compliance teams usually review how each finding is evidenced, how research is labelled and presented, how client data is isolated and where it is held, who reviews outputs and which party is responsible for each step. Reuben AI documents these points in writing so reviews can start before the partnership call.
The problem today
- AI outputs without evidence are hard for compliance teams to approve.
- Unclear responsibilities slow every partnership review.
- Data residency questions arrive late in the process.
How Reuben AI helps
Evidenced findings. Every finding is fully sourced and marked verified or cross-checked.
Clear labelling. Research can be labelled as general information, with the platform choosing disclaimers that fit its licence.
Data isolation. Partner data is isolated, with access control and an audit trail on every record.
Residency choice. Data can be held in APAC, EMEA or the Americas.
Compliance review checklist
- How each finding is sourced and checked
- How research is labelled and which disclaimers apply
- Who reviews outputs before clients see them
- How client and partner data is isolated
- Where data is held
- Which party is responsible for each step
What you get
- Review checklist
- Security and residency summary
- Responsibilities outline
Security and trust
- Client data is isolated, with access control and an audit trail on every record.
- Data residency is available in APAC, EMEA or the Americas.
- Every finding is fully sourced and marked verified or cross-checked.
- People make the decisions. Reuben AI does not give investment advice.